Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer

British Journal of Cancer

Volumn 75, Issue 5, 1997, Pages 634-638

  Deguchi, T ^a   Yang, M ^a   Ehara, H ^a   Ito, S ^b   Nishino, Y ^a   Takahashi, Y ^a   Ito, Y ^b   Shimokawa, K ^a   Tanaka, T ^a   Imaeda, T ^a   Doi, T ^b   Kawada, Y ^a  

^a GIFU UNIVERSITY   (Japan)

^b Gifu Municipal Hospital   (Japan)

Author keywords

Bone marrow; Micrometastases; Prostate cancer; Prostate specific antigen; Reverse transcription polymerase chain reaction

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE MARROW METASTASIS; BONE SCINTISCANNING; CANCER CELL; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 8044247812     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.114     Document Type: Article

References (24)

1. Bretton PR, Melamed MR, Fair WR and Cote RJ (1994) Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma. Prostate 25: 108-114
2. Chybowski FM, Larson Keller JJ, Bergstralh EJ and Oesterling JE (1991) Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer; prostate specific antigen is superior to all other clinical parameters. J Urol 145: 313-318
3. Cote RJ, Rosen PP, Lesser ML, Old LJ and Osborne MP (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756
4. Deguchi T, Kuriyama M, Shinoda I, Okanao M, Ban Y, Matsui H, Yamada A, Saito I and Kawada Y (1991) Immunological comparison between prostate-specific antigen and γ-seminoprotein. Urol Res 19: 25-30
5. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanaka T and Kawada Y (1993) Detection of micrometastitic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53: 5350 5354
6. Eschwege P, Dumas F, Blanchet P, LE Maire V, Benoit G, Jardin A, Lacour B and Loric S (1995) Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 346: 1528-1530
7. Fair WR, Aprikian A, Sogani P, Reuter V and Whitmore WFJr (1993) The role of neoadjuvant hormonal manipulation in localized prostatic cancer. Cancer 71 (suppl.): 1031-1038
8. Israeli RS, Miller WHJr, Su SL, Powell T, Fair WR, Samadu DS, Huryk RF,. Deblasio A, Edwards ET, Wise GJ and Heston WDW (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells; comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306-6310
9. Katz AE, Seaman E, Olsson CA, Otoole KM, Raffo AJ, McMahon D, Cama C, Benson MC, Perlma H and Buttyun R (1994) Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43: 765-775
10. Kleer E, Larson Keller JJ, Zincke H and Osterling JE (1993) Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Urology 41: 207-216
11. Kuriyama M, Esaki N, Shinoda I, Ito S, Yamada S, Tokuyama K, Deguchi T, Takahashi Y and Kawada Y (1993) Measurement of serum PA values by a newly developed enzyme immunoassay. Jpn J Urol 84: 244-250
12. Kwok S (1990) Procedures to minimize PCR product carry-over. In PCR Protocols: A Guide to Methods and Applications, Innis MA, Gelfand DH, Sminsky JJ and White TJ (eds), pp. 142-145. Academic press: San Diego.
13. Lerner SP, Seale-Hawkins C, Caelton CE Jr and Scardino PT (1991) The risk of dying of prostate cancer in patients with clinically localized disease. J Urol 146: 1040-1045
14. Lindenmann F, Schlimok G, Dirschedl P and Riethmuller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689
15. Mansi JL, Berger U, Wilson P, Shearer R and Coombes RC (1988) Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 139: 545-548
16. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland G and Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110-6112
17. Oberneder R, Riesenberg R, Kriegmair M, Bitzer U, Klammert R, Schneede P, Hofstetter A, Riethmuller G and Pantel K (1994) Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urol Res 22: 3-8
18. Osterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923
19. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, Thetter O and Riethmuller G (1993) Immunological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53: 1027-1031
20. Schellhammer PF (1988) Radical prostatectomy: patterns of local failure and survival in 67 patients. Urology 31: 191-197
21. Schlimok G, Funke I, Pantel K, Strobel F, Lindenmann F, Witte J and Riethmuller G (1991) Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27: 1461-1465
22. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK and Pavone-Macaluso M (1992) The TNM classification of prostate cancer. Prostate 4 (suppl.): 129-138
23. Wood DPJr, Banks FR, Humphreys S and Rangnekar VM (1994a) Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J Histochem Cytochem 42: 505-511
24. Wood DPJr, Banks ER, Humphreys S, McRoberts JW and Rangnekar VM (1994b) Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533-2540